Insulet
We're hiring — explore open roles below and apply in a few clicks.
Location
Headquarters: Acton, Massachusetts, United States, North America
Region: Massachusetts
Country: US
Continent: North America
About
Insulet Corporation develops and markets diabetes management solutions, most notably Omnipod tubeless insulin pump systems. The company operates globally with a focus on patient-centered diabetes care, enabling continuous insulin delivery without tubing. Its products aim to improve quality of life for people with diabetes by simplifying insulin management and reducing treatment burden. Headquartered in the United States, Insulet emphasizes innovation in medical devices for diabetes care.
Insulet Corporation develops and markets diabetes management solutions, primarily through its Omnipod tubeless insulin pump systems. The company provides wearable devices that enable continuous subcutaneous insulin delivery without the need for needles or tubing. Its products are designed to simplify insulin management and improve the quality of life for patients with diabetes globally.
Insulet Corporation
2000
for_profit
active
Industries
Primary Industry: Manufacturing
Categories
Funding & Financials
Public Company
$629.5M
over-1b
ipo
NASDAQ:PODD
nasdaq
Investors
Founders
Hans Werner Sollinger
Shacey Petrovic
Leadership
Ashley McEvoy — President & Chief Executive Officer
Hjalte Hojsgaard — Sr. Regional Business Director
Annette Ballou — Senior Director, Strategic Alliances
Bret Christensen — Chief Commercial Officer
Charles Liamos — Chief Operating Officer
Patrick Sullivan — President & CEO
Shacey Petrovic — President & Chief Executive Officer & Co-Founder
Jason Wills — Senior Consumer Marketing Manager, International
Patrick Sullivan — board_member
Timothy Scannell — board_member
Technology Stack
Products
Omnipod 5 Automated Insulin Delivery System: A wearable insulin pump system that delivers insulin continuously and adjusts doses automatically based on glucose levels for people with type 1 and type 2 diabetes.
Omnipod Insulin Management System: A wearable, tubeless insulin pump system that delivers continuous insulin to people with diabetes without multiple daily injections.
Omnipod 5 Automated Insulin Delivery System: An automated insulin delivery system that integrates continuous insulin delivery with algorithm-driven insulin dosing for diabetes management.
Omnipod DASH Insulin Management System: A tubeless insulin pump system that delivers insulin at set and variable rates for diabetes management, interoperable with compatible blood glucose meters.
Omnipod DASH System: A tubeless, wearable insulin pump system that provides continuous insulin delivery with wireless control for diabetes management.
Funding rounds
Post Ipo Debt · $450M · (2025-03-18)
Post Ipo Debt · $60M · (2009-03-16) · Lead: Deerfield
IPO · (2007-05-15)
Connect
Connect
Open positions(4)
- Senior Software Engineer, iOS (On-site - Acton, MA)Full-timeWork from OfficeActon, Massachusetts128,000–191,975 / Year
- Senior Software Engineer, iOS (Hybrid - San Diego, CA or Acton, MA)Full-timeHybridSan Diego, California140,800–211,150 / Year
- Software Engineer, Android (Hybrid - San Diego, CA or Acton, MA)Full-timeHybridSan Diego, California122,600–175,625 / Year
- Staff Product Experience Strategist/Lead UX Designer(Hybrid-Acton, MA or San Diego, CA)Full-timeHybridSan Diego, California156,600–234,900 / Year